Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$0.390
-0.0015 (-0.383%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clene Inc. prices

Date Open High Low Close Volume
Dec 13, 2023 $0.405 $0.419 $0.383 $0.410 575 142
Dec 12, 2023 $0.400 $0.400 $0.354 $0.354 293 111
Dec 11, 2023 $0.405 $0.405 $0.377 $0.378 246 688
Dec 08, 2023 $0.410 $0.420 $0.377 $0.389 294 694
Dec 07, 2023 $0.420 $0.420 $0.396 $0.407 315 502
Dec 06, 2023 $0.420 $0.420 $0.393 $0.400 314 922
Dec 05, 2023 $0.403 $0.440 $0.390 $0.400 355 420
Dec 04, 2023 $0.434 $0.449 $0.400 $0.419 373 381
Dec 01, 2023 $0.447 $0.450 $0.418 $0.434 212 856
Nov 30, 2023 $0.451 $0.455 $0.425 $0.438 283 192
Nov 29, 2023 $0.446 $0.465 $0.440 $0.450 76 822
Nov 28, 2023 $0.465 $0.486 $0.440 $0.448 322 762
Nov 27, 2023 $0.476 $0.500 $0.460 $0.460 575 329
Nov 24, 2023 $0.463 $0.484 $0.455 $0.460 171 475
Nov 22, 2023 $0.440 $0.480 $0.440 $0.475 106 851
Nov 21, 2023 $0.475 $0.494 $0.451 $0.456 288 675
Nov 20, 2023 $0.490 $0.490 $0.433 $0.471 185 808
Nov 17, 2023 $0.456 $0.460 $0.440 $0.454 193 582
Nov 16, 2023 $0.470 $0.475 $0.440 $0.460 103 536
Nov 15, 2023 $0.480 $0.480 $0.426 $0.441 216 790
Nov 14, 2023 $0.462 $0.480 $0.430 $0.438 200 952
Nov 13, 2023 $0.419 $0.470 $0.419 $0.469 324 666
Nov 10, 2023 $0.412 $0.450 $0.390 $0.450 505 292
Nov 09, 2023 $0.426 $0.444 $0.390 $0.401 146 966
Nov 08, 2023 $0.450 $0.450 $0.402 $0.416 332 769
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT